Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Recombinant interferon beta‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Detalles Bibliográficos
Autores principales: Gupta, Mrinal, Yamauchi, Paul S., Bagot, Martine, Szepietowski, Jacek, Bhatia, Shibani, Lotti, Torello, Goldust, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495805/
https://www.ncbi.nlm.nih.gov/pubmed/32983469
http://dx.doi.org/10.1002/ccr3.2971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495805/
https://www.ncbi.nlm.nih.gov/pubmed/32983469
http://dx.doi.org/10.1002/ccr3.2971

Ejemplares similares